Viking Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
VKTX on Nasdaq
Location
9920 Pacific Heights Blvd, Suite 350, San Diego, CA

Insiders trading volume in the past year

Viking Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Lian President & CEO, Director $84.7M -$10.4M -11% Oct 27, 2025
Marianna Mancini Chief Operating Officer $13.4M -$2.65M -16.5% Oct 27, 2025
Greg Zante Chief Financial Officer $6.08M -$2.49M -29% Oct 27, 2025
Lawson Macartney Director $3.29M Jan 2, 2025
Charles A. Rowland Jr Director $1.07M -$2.13M -66.7% Oct 27, 2025
Matthew W. Foehr Director $1.06M Apr 11, 2025
J. Matthew Singleton Director $755K Jan 2, 2025
Sarah Kathryn Rouan Director $29.9K +$29.9K Mar 31, 2025

Recent Insider Transactions by Companies or Individuals for Viking Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.